Non-coding RNA as Therapeutic Target: A Game Changer in Cardiac Regenerative Strategies?

48.3K
views
59
authors
10
articles
Editors
3
Impact
Loading...
6,270 views
31 citations
Review
25 September 2020
Extracellular Vesicle miRNAs in the Promotion of Cardiac Neovascularisation
Despoina Kesidou
4 more and 
Andrew Howard Baker

Cardiovascular disease (CVD) is the leading cause of mortality worldwide claiming almost 17. 9 million deaths annually. A primary cause is atherosclerosis within the coronary arteries, which restricts blood flow to the heart muscle resulting in myocardial infarction (MI) and cardiac cell death. Despite substantial progress in the management of coronary heart disease (CHD), there is still a significant number of patients developing chronic heart failure post-MI. Recent research has been focused on promoting neovascularisation post-MI with the ultimate goal being to reduce the extent of injury and improve function in the failing myocardium. Cardiac cell transplantation studies in pre-clinical models have shown improvement in cardiac function; nonetheless, poor retention of the cells has indicated a paracrine mechanism for the observed improvement. Cell communication in a paracrine manner is controlled by various mechanisms, including extracellular vesicles (EVs). EVs have emerged as novel regulators of intercellular communication, by transferring molecules able to influence molecular pathways in the recipient cell. Several studies have demonstrated the ability of EVs to stimulate angiogenesis by transferring microRNA (miRNA, miR) molecules to endothelial cells (ECs). In this review, we describe the process of neovascularisation and current developments in modulating neovascularisation in the heart using miRNAs and EV-bound miRNAs. Furthermore, we critically evaluate methods used in cell culture, EV isolation and administration.

8,952 views
36 citations
5,478 views
20 citations
Original Research
29 May 2020
6,101 views
27 citations
Open for submission
Frontiers Logo

Frontiers in Pharmacology

Advancements in Therapeutic Strategies for Skeletal Muscle and Cardiovascular Diseases: Integrating Innovative Approaches for Enhanced Outcomes
Edited by Roberta Stilhano, Leonardo Martin, Priscila Keiko Matsumoto Martin
Deadline
26 August 2025
Submit a paper
Recommended Research Topics
Frontiers Logo

Frontiers in Pharmacology

Fetal Therapies and Maternal-Fetal Tolerance
Edited by Graca Almeida-Porada, Tippi C. MacKenzie
69.8K
views
34
authors
11
articles
Frontiers Logo

Frontiers in Pharmacology

Cardio-Protection and Heart Repair: New Drugs, Targets and Approaches
Edited by Benzhi Cai, Hua Zhu, Naufal Zagidullin
300.4K
views
456
authors
59
articles
Frontiers Logo

Frontiers in Cellular Neuroscience

Mesenchymal Stromal Cell Therapy for Regenerative Medicine
Edited by Vivian Capilla-González, Vicente Herranz-Pérez, Rachel Sarabia Estrada, Guido Moll, Nadir Kadri
333.7K
views
280
authors
38
articles
Frontiers Logo

Frontiers in Pharmacology

Recent Trends in Pharmacological Treatment of Musculoskeletal Disorders
Edited by Sien Lin, Liangliang Xu, Ning Zhang, Wing-Hoi Cheung
141.1K
views
166
authors
21
articles
Frontiers Logo

Frontiers in Neurology

Transforming Neurological Recovery: The Promise of Regenerative Neurorehabilitation
Edited by Stefania Dalise, Carmelo Chisari, Mike Modo, Federico Cremisi, Claudia Alia
Deadline
20 Jun 2025
Submit